Press Resease

Bioresorbable Implants Market - Global Industry Analysis

Bioresorbable Implants Market by Type (Metallic and Polymer), by Application (Orthopedic, Cardiovascular, and Others), and by End-User (Hospital, Ambulatory Surgical Centers, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2027

Published Date: 30-May-2019 Category: Medical Device Report Format : PDF Pages: 140 Report Code: ZMR-3941 Status : Published

Global bioresorbable implants market expected to generate around USD 10,041 million by 2027, at a CAGR of around 8.1% between 2019 and 2027. Bioresorbable implants play a key role in advanced healthcare, as they improve and support damaged biological structure in the body.

Description

The report covers a forecast and an analysis of the bioresorbable implants market on a global and regional level. The study provides historical data from 2017 and 2018 along with a forecast from 2019 to 2027 based on revenue (USD Million). The study includes the drivers and restraints of the bioresorbable implants market along with their impact on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the bioresorbable implants market on a global level.

In order to give the users of this report a comprehensive view of the bioresorbable implants market, we have included a competitive landscape and an analysis of Porter's Five Forces Model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.

Global Bioresorbable Implants Market

The report provides company market share analysis to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the market on a global and regional basis. Moreover, the study covers the product portfolio of various companies according to regions.

The study provides a decisive view of the bioresorbable implants market by segmenting it based on type, application, end-user, and region. The regional segment of the market includes North America, Europe, Latin America, Asia Pacific, and the Middle East and Africa.

Some major players of the global bioresorbable implants market are Bioretec, CONMED Corporation, DePuy Synthes, Stryker Corporation, Zimmer Biomet Holdings, Smith & Nephew, and Boston Scientific Corporation.

This report segments the global bioresorbable implants market into:

Global Bioresorbable Implants Market: Type Analysis

  • Metallic
  • Polymer
    • PLGA-Poly lactic-co-glycolic acid
    • PLLA-Poly L-lactide
    • PGA-Polyglycolic Acid
    • PLA-Polylactic Acid
    • Others

Global Bioresorbable Implants Market: Application Analysis

  • Orthopedic
  • Cardiovascular
  • Others

Global Bioresorbable Implants Market: End-User Analysis

  • Hospital
  • Ambulatory Surgical Centers
  • Others

Global Bioresorbable Implants Market: Regional Analysis

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Table Of Content

  • Chapter 1. Introduction
    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology
      • 1.3.1. Market research process
      • 1.3.2. Market research methodology
  •  
  • Chapter 2. Executive Summary
    • 2.1. Global Bioresorbable Implants Market, 2017-2027 (USD Million)
    • 2.2. Global Bioresorbable Implants Market: Snapshot
  •  
  • Chapter 3. Bioresorbable Implants Market - Industry Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Global Bioresorbable Implants Market drivers: Impact analysis
      • 3.2.2. Technological advancements in medical implants
      • 3.2.3. Increasing incidences of trauma associated with skeletal injuries
      • 3.2.4. The global rise in acceptance of bioresorbable implants
      • 3.2.5. Growing R&D activities on bioresorbable implants
    • 3.3. Market Restraints
      • 3.3.1. Safety issues due to bioresorbable implants
      • 3.3.2. Unfavorable government reimbursement policy
      • 3.3.3. The high cost of treatment
    • 3.4. Opportunities
      • 3.4.1. Huge market opportunities in developing countries
      • 3.4.2. Growing awareness among patients and a rising preference for a better quality of life
      • 3.4.3. Growth in the development of minimally-invasive and non-surgical procedures
    • 3.5. Porter's Five Forces Analysis
    • 3.6. Market Attractiveness Analysis
      • 3.6.1. Market attractiveness analysis, by Type
      • 3.6.2. Market attractiveness analysis, by Application
      • 3.6.3. Market attractiveness analysis, by End-user
      • 3.6.4. Market attractiveness analysis, by region
  •  
  • Chapter 4. Global Bioresorbable Implants Market - Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global Bioresorbable Implants Market: company market share, 2018
    • 4.2. Strategic development
      • 4.2.1.
      • Acquisitions & mergers
      • 4.2.2. New Product Launch
      • 4.2.3. Agreements, partnerships, collaborations and joint ventures
      • 4.2.4.
      • Research and development and regional expansion
  •  
  • Chapter 5. Global Bioresorbable Implants Market - Type Analysis
    • 5.1. Global Bioresorbable Implants Market: type overview
      • 5.1.1. Global Bioresorbable Implants Market revenue share, by Type, 2018 and 2027
    • 5.2. Metallic
      • 5.2.1. Global Bioresorbable Implants Market for Metallic, 2017-2027 (USD Million)
    • 5.3. Polymer
      • 5.3.1. Global Bioresorbable Implants Market for Polymer, 2017-2027 (USD Million)
  •  
  • Chapter 6. Global Bioresorbable Implants Market - Application Analysis
    • 6.1. Global Bioresorbable Implants Market: Application overview
      • 6.1.1. Global Bioresorbable Implants Market revenue share, by Application, 2018 and 2027
    • 6.2. Orthopedic
      • 6.2.1. Global Bioresorbable Implants Market for Orthopedic, 2017-2027 (USD Million)
    • 6.3. Cardiovascular
      • 6.3.1. Global Bioresorbable Implants Market for Cardiovascular, 2017-2027 (USD Million)
    • 6.4. Cardiovascular
      • 6.4.1. Global Bioresorbable Implants Market for Cardiovascular, 2017-2027 (USD Million)
    • 6.5. Other Application
      • 6.5.1. Global Bioresorbable Implants Market for Other Application, 2017-2027 (USD Million)
  •  
  • Chapter 7. Global Bioresorbable Implants Market - End-User Segment Analysis
    • 7.1. Global Bioresorbable Implants Market: End-User overview
      • 7.1.1. Global Bioresorbable Implants Market revenue share, by End-User, 2018 and 2027
    • 7.2. Hospitals
      • 7.2.1. Global Bioresorbable Implants Market for Orthopedic, 2017-2027 (USD Million)
    • 7.3. Ambulatory surgical center
      • 7.3.1. Global Bioresorbable Implants Market for Cardiovascular, 2017-2027 (USD Million)
    • 7.4. Others
      • 7.4.1. Global Bioresorbable Implants Market for Others, 2017-2027 (USD Million)
  •  
  • Chapter 8. Global Bioresorbable Implants Market - Regional Analysis
    • 8.1. Global Bioresorbable Implants Market: regional overview
      • 8.1.1. Global Bioresorbable Implants Market revenue share, by region, 2018 and 2027
    • 8.2. North America
      • 8.2.1. North America Bioresorbable Implants Market Revenue, by Type, 2017-2027 (USD Million)
      • 8.2.2. North America Bioresorbable Implants Market Revenue, by Application, 2017-2027 (USD Million)
      • 8.2.3. North America Bioresorbable Implants Market revenue, by End-User, 2017-2027 (USD Million)
      • 8.2.4. The U.S.
        • 8.2.4.1. The U.S. Bioresorbable Implants Market Revenue, by Type, 2017-2027 (USD Million)
        • 8.2.4.2. The U.S. Bioresorbable Implants Market Revenue, by Application, 2017-2027 (USD Million)
        • 8.2.4.3. The U.S. Bioresorbable Implants Market revenue, by End-User, 2017-2027 (USD Million)
      • 8.2.5. Canada
        • 8.2.5.1. Canada Bioresorbable Implants Market Revenue, by Type, 2017-2027 (USD Million)
        • 8.2.5.2. Canada Bioresorbable Implants Market Revenue, by Application, 2017-2027 (USD Million)
        • 8.2.5.3. Canada Bioresorbable Implants Market revenue, by End-User, 2017-2027 (USD Million)
      • 8.2.6. Mexico
        • 8.2.6.1. Mexico Bioresorbable Implants Market Revenue, by Type, 2017-2027 (USD Million)
        • 8.2.6.2. Mexico Bioresorbable Implants Market Revenue, by Application, 2017-2027 (USD Million)
        • 8.2.6.3. Mexico Bioresorbable Implants Market revenue, by End-User, 2017-2027 (USD Million)
    • 8.3. Europe
      • 8.3.1. Europe Bioresorbable Implants Market Revenue, by Type, 2017-2027 (USD Million)
      • 8.3.2. Europe Bioresorbable Implants Market Revenue, by Application, 2017-2027 (USD Million)
      • 8.3.3. Europe Bioresorbable Implants Market revenue, by End-User, 2017-2027 (USD Million)
      • 8.3.4. U.K.
        • 8.3.4.1. U.K. Bioresorbable Implants Market Revenue, by Type, 2017-2027 (USD Million)
        • 8.3.4.2. U.K. Bioresorbable Implants Market Revenue, by Application, 2017-2027 (USD Million)
        • 8.3.4.3. U.K. Bioresorbable Implants Market revenue, by End-User, 2017-2027 (USD Million)
      • 8.3.5. Germany
        • 8.3.5.1. Germany Bioresorbable Implants Market Revenue, by Type, 2017-2027 (USD Million)
        • 8.3.5.2. Germany Bioresorbable Implants Market Revenue, by Application, 2017-2027 (USD Million)
        • 8.3.5.3. Germany Bioresorbable Implants Market revenue, by End-User, 2017-2027 (USD Million)
      • 8.3.6. France
        • 8.3.6.1. France Bioresorbable Implants Market Revenue, by Type, 2017-2027 (USD Million)
        • 8.3.6.2. France Bioresorbable Implants Market Revenue, by Application, 2017-2027 (USD Million)
        • 8.3.6.3. France Bioresorbable Implants Market revenue, by End-User, 2017-2027 (USD Million)
      • 8.3.7. Italy
        • 8.3.7.1. Italy Bioresorbable Implants Market Revenue, by Type, 2017-2027 (USD Million)
        • 8.3.7.2. Italy Bioresorbable Implants Market Revenue, by Application, 2017-2027 (USD Million)
        • 8.3.7.3. Italy Bioresorbable Implants Market revenue, by End-User, 2017-2027 (USD Million)
      • 8.3.8. Spain
        • 8.3.8.1. Spain Bioresorbable Implants Market Revenue, by Type, 2017-2027 (USD Million)
        • 8.3.8.2. Spain Bioresorbable Implants Market Revenue, by Application, 2017-2027 (USD Million)
        • 8.3.8.3. Spain Bioresorbable Implants Market revenue, by End-User, 2017-2027 (USD Million)
      • 8.3.9. Rest of Europe
        • 8.3.9.1. Rest of Europe Bioresorbable Implants Market Revenue, by Type, 2017-2027 (USD Million)
        • 8.3.9.2. Rest of Europe Bioresorbable Implants Market Revenue, by Application, 2017-2027 (USD Million)
        • 8.3.9.3. Rest of Europe Bioresorbable Implants Market revenue, by End-User, 2017-2027 (USD Million)
    • 8.4. Asia Pacific
      • 8.4.1. Asia Pacific Bioresorbable Implants Market Revenue, by Type, 2017-2027 (USD Million)
      • 8.4.2. Asia Pacific Bioresorbable Implants Market Revenue, by Application, 2017-2027 (USD Million)
      • 8.4.3. Asia Pacific Bioresorbable Implants Market revenue, by End-User, 2017-2027 (USD Million)
      • 8.4.4. China
        • 8.4.4.1. China Bioresorbable Implants Market Revenue, by Type, 2017-2027 (USD Million)
        • 8.4.4.2. China Bioresorbable Implants Market Revenue, by Application, 2017-2027 (USD Million)
        • 8.4.4.3. China Bioresorbable Implants Market revenue, by End-User, 2017-2027 (USD Million)
      • 8.4.5. Japan
        • 8.4.5.1. Japan Bioresorbable Implants Market Revenue, by Type, 2017-2027 (USD Million)
        • 8.4.5.2. Japan Bioresorbable Implants Market Revenue, by Application, 2017-2027 (USD Million)
        • 8.4.5.3. Japan Bioresorbable Implants Market revenue, by End-User, 2017-2027 (USD Million)
      • 8.4.6. India
        • 8.4.6.1. India Bioresorbable Implants Market Revenue, by Type, 2017-2027 (USD Million)
        • 8.4.6.2. India Bioresorbable Implants Market Revenue, by Application, 2017-2027 (USD Million)
        • 8.4.6.3. India Bioresorbable Implants Market revenue, by End-User, 2017-2027 (USD Million)
      • 8.4.7. Australia
        • 8.4.7.1. Australia Bioresorbable Implants Market Revenue, by Type, 2017-2027 (USD Million)
        • 8.4.7.2. Australia Bioresorbable Implants Market Revenue, by Application, 2017-2027 (USD Million)
        • 8.4.7.3. Australia Bioresorbable Implants Market revenue, by End-User, 2017-2027 (USD Million)
      • 8.4.8. New Zealand
        • 8.4.8.1. New Zealand Bioresorbable Implants Market Revenue, by Type, 2017-2027 (USD Million)
        • 8.4.8.2. New Zealand Bioresorbable Implants Market Revenue, by Application, 2017-2027 (USD Million)
        • 8.4.8.3. New Zealand Bioresorbable Implants Market revenue, by End-User, 2017-2027 (USD Million)
      • 8.4.9. Rest of Asia Pacific
        • 8.4.9.1. Rest of Asia Pacific Bioresorbable Implants Market Revenue, by Type, 2017-2027 (USD Million)
        • 8.4.9.2. Rest of Asia Pacific Bioresorbable Implants Market Revenue, by Application, 2017-2027 (USD Million)
        • 8.4.9.3. Rest of Asia Pacific Bioresorbable Implants Market revenue, by End-User, 2017-2027 (USD Million)
    • 8.5. Latin America
      • 8.5.1. Latin America Bioresorbable Implants Market Revenue, by Type, 2017-2027 (USD Million)
      • 8.5.2. Latin America Bioresorbable Implants Market Revenue, by Application, 2017-2027 (USD Million)
      • 8.5.3. Latin America Bioresorbable Implants Market revenue, by End-User, 2017-2027 (USD Million)
      • 8.5.4. Brazil
        • 8.5.4.1. Brazil Bioresorbable Implants Market Revenue, by Type, 2017-2027 (USD Million)
        • 8.5.4.2. Brazil Bioresorbable Implants Market Revenue, by Application, 2017-2027 (USD Million)
        • 8.5.4.3. Brazil Bioresorbable Implants Market revenue, by End-User, 2017-2027 (USD Million)
      • 8.5.5. Argentina
        • 8.5.5.1. Argentina Bioresorbable Implants Market Revenue, by Type, 2017-2027 (USD Million)
        • 8.5.5.2. Argentina Bioresorbable Implants Market Revenue, by Application, 2017-2027 (USD Million)
        • 8.5.5.3. Argentina Bioresorbable Implants Market revenue, by End-User, 2017-2027 (USD Million)
      • 8.5.6. Rest of Latin America
        • 8.5.6.1. Rest of Latin America Bioresorbable Implants Market Revenue, by Type, 2017-2027 (USD Million)
        • 8.5.6.2. Rest of Latin America Bioresorbable Implants Market Revenue, by Application, 2017-2027 (USD Million)
        • 8.5.6.3. Rest of Latin America Bioresorbable Implants Market revenue, by End-User, 2017-2027 (USD Million)
    • 8.6. The Middle East and Africa
      • 8.6.1. The Middle East and Africa Bioresorbable Implants Market Revenue, by Type, 2017-2027 (USD Million)
      • 8.6.2. The Middle East and Africa Bioresorbable Implants Market Revenue, by Application, 2017-2027 (USD Million)
      • 8.6.3. The Middle East and Africa Bioresorbable Implants Market revenue, by End-User, 2017-2027 (USD Million)
      • 8.6.4. Saudi Arabia
        • 8.6.4.1. Saudi Arabia Bioresorbable Implants Market Revenue, by Type, 2017-2027 (USD Million)
        • 8.6.4.2. Saudi Arabia Bioresorbable Implants Market Revenue, by Application, 2017-2027 (USD Million)
        • 8.6.4.3. Saudi Arabia Bioresorbable Implants Market revenue, by End-User, 2017-2027 (USD Million)
      • 8.6.5. UAE
        • 8.6.5.1. UAE Bioresorbable Implants Market Revenue, by Type, 2017-2027 (USD Million)
        • 8.6.5.2. UAE Bioresorbable Implants Market Revenue, by Application, 2017-2027 (USD Million)
        • 8.6.5.3. UAE Bioresorbable Implants Market revenue, by End-User, 2017-2027 (USD Million)
      • 8.6.6. South Africa
        • 8.6.6.1. South Africa Bioresorbable Implants Market Revenue, by Type, 2017-2027 (USD Million)
        • 8.6.6.2. South Africa Bioresorbable Implants Market Revenue, by Application, 2017-2027 (USD Million)
        • 8.6.6.3. South Africa Bioresorbable Implants Market revenue, by End-User, 2017-2027 (USD Million)
  •  
  • Chapter 9. Company Profile
    • 9.1. Bioretec
      • 9.1.1. Overview
      • 9.1.2. Financials
      • 9.1.3. Product portfolio
      • 9.1.4. Business strategy
      • 9.1.5. Recent developments
    • 9.2. CONMED Corporation
      • 9.2.1. Overview
      • 9.2.2. Financials
      • 9.2.3. Product portfolio
      • 9.2.4. Business strategy
      • 9.2.5. Recent developments
    • 9.3. DePuy Synthes
      • 9.3.1. Overview
      • 9.3.2. Financials
      • 9.3.3. Product portfolio
      • 9.3.4. Business strategy
      • 9.3.5. Recent developments
    • 9.4. Stryker Corporation
      • 9.4.1. Overview
      • 9.4.2. Financials
      • 9.4.3. Product portfolio
      • 9.4.4. Business strategy
      • 9.4.5. Recent developments
    • 9.5. Zimmer Biomet Holdings
      • 9.5.1. Overview
      • 9.5.2. Financials
      • 9.5.3. Product portfolio
      • 9.5.4. Business strategy
      • 9.5.5. Recent developments
    • 9.6. Smith & Nephew
      • 9.6.1. Overview
      • 9.6.2. Financials
      • 9.6.3. Product portfolio
      • 9.6.4. Business strategy
      • 9.6.5. Recent developments
    • 9.7. Boston Scientific Corporation
      • 9.7.1. Overview
      • 9.7.2. Financials
      • 9.7.3. Product portfolio
      • 9.7.4. Business strategy
      • 9.7.5. Recent developments

Methodology

Free Analysis

A medical implant that is made up of a material that can be absorbed by the body is known as a bioresorbable implant. These implants disintegrate with the change in time; in other words, there is a direct relationship between the implant’s disintegration and time, and its stresses are transferred into healing tissues. It provides temporary support to the body to heal the damaged tissues, post which it disappears. The implant’s actual benefit is that the tissues get temporary help to perform their original task.

Bioresorbable implants are used in numerous orthopedic, dental, and cardiovascular surgeries, which is the primary growth driver of the bioresorbable implants market globally. Furthermore, the high incidence of cardiovascular disease globally is anticipated to propel the demand for bioresorbable implants for cardiovascular surgeries, which, in turn, is predicted to boost the global bioresorbable implants market development over the forecast time period. Moreover, the increasing incidences of skeletal injuries are also likely to boost the bioresorbable implants market globally in the future. According to the WHO (World Health Organization), in 2018, road accidents caused between 20 and 50 million injuries annually around the world. Moreover, in road crashes, about 1.25 million people die every year, i.e., an average of 3,287 deaths per day. Road traffic injuries are the foremost cause of death among people aged between 5 and 29 years. Additionally, the growing competition among the key players operating in the bioresorbable implants market for the development of innovative solutions is further anticipated to propel this market’s growth in the future.

Global Bioresorbable Implants Market

The global bioresorbable implants market is categorized into type, application, and end-user. On the basis of type, the bioresorbable implants market includes metallic and polymer. The polymer segment is further divided into PLLA- Poly L-lactide, PLGA- Poly lactic-co-glycolic acid, PLA- Polylactic Acid, PGA- Polyglycolic Acid, and others. By application, the global bioresorbable implants market is fragmented into orthopedic, cardiovascular, and others. On the basis of end-user, the global bioresorbable implants market includes hospitals, ambulatory surgical centers, and others.

By geography, North America accounted for the largest share of the global market in 2018 and is anticipated to remain the leading region over the forecast time period as well. The Asia Pacific region is expected to register the highest rate of growth in the global bioresorbable implants market in the future.

Some major players of the global bioresorbable implants market are Bioretec, CONMED Corporation, DePuy Synthes, Stryker Corporation, Zimmer Biomet Holdings, Smith & Nephew, and Boston Scientific Corporation.

Choose License Type

Request the coronavirus impact analysis across industries and markets

HappyClients

Office Address

Corporate Office

Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com

We Are On Social